Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,241 to 1,260 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseases. | Genome Med | 2021 | 34645491 | PubTator, text mining | PubMed |
| In silico and multi-spectroscopic analyses on the interaction of 5-amino-8-hydroxyquinoline and bovine serum albumin as a potential anticancer agent. | Sci Rep | 2021 | 34642420 | PubTator, text mining | PubMed |
| ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer Control. | Int J Mol Sci | 2021 | 34639169 | PubTator, text mining | PubMed |
| Esterase Activity of Serum Albumin Studied by 1H NMR Spectroscopy and Molecular Modelling. | Int J Mol Sci | 2021 | 34638934 | PubTator, text mining | PubMed |
| Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy. | Int J Mol Sci | 2021 | 34638744 | PubTator, text mining | PubMed |
| Serum Albumin in Health and Disease: Esterase, Antioxidant, Transporting and Signaling Properties. | Int J Mol Sci | 2021 | 34638659 | PubTator, text mining | PubMed |
| Identification of Estrogen Signaling in a Prioritization Study of Intraocular Pressure-Associated Genes. | Int J Mol Sci | 2021 | 34638643 | PubTator, text mining | PubMed |
| Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia-From Molecular Mechanisms to Clinical Relevance. | Cancers (Basel) | 2021 | 34638304 | PubTator, text mining | PubMed |
| Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell Regulation. | Cancers (Basel) | 2021 | 34638302 | PubTator, text mining | PubMed |
| Proceedings of the 9th International Symposium on MDS and SAA in Childhood : Athens, Greece. 30 September-2 October 2021. | Mol Cell Pediatr | 2021 | 34633564 | PubTator, text mining | PubMed |
| A Case Report of Metastatic Castration-Resistant Prostate Cancer Harboring a PTEN Loss. | Front Oncol | 2021 | 34631559 | PubTator, text mining | PubMed |
| A Different View for an Old Disease: NEDDylation and Other Ubiquitin-Like Post-Translational Modifications in Chronic Lymphocytic Leukemia. | Front Oncol | 2021 | 34631557 | PubTator, text mining | PubMed |
| Replacing the SpCas9 HNH domain by deaminases generates compact base editors with an alternative targeting scope. | Mol Ther Nucleic Acids | 2021 | 34631280 | PubTator, text mining | PubMed |
| Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients. | BMC Pediatr | 2021 | 34629063 | PubTator, text mining | PubMed |
| Genome-wide whole-blood transcriptome profiling across inherited bone marrow failure subtypes. | Blood Adv | 2021 | 34625797 | PubTator, text mining | PubMed |
| Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506. | Mol Cancer Ther | 2021 | 34625504 | PubTator, text mining | PubMed |
| Isolation of human and murine hematopoietic stem cells for DNA damage and DNA repair assays. | STAR Protoc | 2021 | 34622219 | PubTator, text mining | PubMed |
| Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes. | Nat Med | 2021 | 34621053 | PubTator, text mining | PubMed |
| Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer. | Gynecol Oncol | 2021 | 34620496 | PubTator, text mining | PubMed |
| Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With BRAF V600E-Mutated Gliomas. | Cancer Control | 2021 | 34620004 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=63